3Z Pharmaceuticals
Accelerated CNS drug discovery
Accelerated CNS drug discovery
3Z Pharmaceuticals is an Icelandic startup that focuses on accelerating CNS drug discovery. Founded in 2008, the company utilizes advanced disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders. In its latest funding round on 20 June 2022, 3Z Pharmaceuticals secured a $2.00M investment in a Seed Round. The investment was made by undisclosed investors. Specializing in the Health Care and Pharmaceutical industries, 3Z Pharmaceuticals aims to make significant contributions to the field of CNS drug development.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $2.00M | - | 20 Jun 2022 | |
| Seed Round | ISK30.00M | 2 |
|
12 Oct 2020 |
| Grant | ISK50.00M | - | 01 Jun 2020 | |
| Seed Round | $400.00K | 4 |
|
05 Jul 2016 |
| Grant | ISK10.00M | 1 |
|
01 Mar 2016 |
No recent news or press coverage available for 3Z Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
